Author

A. Ocana

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:metagenomics· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. H. Goodall· 1 shared A. Pandiella· 1 shared B. Györffy· 1 shared C. Nieto Jimenez· 1 shared E. Amir· 1 shared E. Kiss-Toth· 1 shared E. M. Galan Moya· 1 shared F. J. C. Felipe· 1 shared

Activity by Year

2018-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. H. Goodall

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

TRIB1 regulates tumour growth via controlling tumour-associated macrophage phenotypes and is associated with breast cancer survival and treatment response

T. Kim, J. Johnston, F. J. C. Felipe, S. Hamby, S. Castillo-Lluva, The Cardiogenics Consortium, A. H. Goodall, G. Velasco, A. Ocana, M. Muthana, E. Kiss-Toth

This paper shows TRIB1 in macrophages affects breast cancer growth and treatment response by altering cytokine levels and immune cell composition.

bioRxiv · Jun 7, 2021 · PreprintCancer Biology

Epigenetic mutational landscape in breast cancer: role of the histone methyltransferase gene KMT2D in triple negative tumors

S. Morcillo Garcia, M. d. M. Noblejas Lopez, C. Nieto Jimenez, J. Perez Pena, M. Nuncia Cantarero, B. Györffy, E. Amir, A. Pandiella, E. M. Galan Moya, A. Ocana

The paper identifies KMT2D mutations in triple negative breast cancer linked to poor prognosis and confirms its prognostic value through transcriptomic analysis.

bioRxiv · Dec 3, 2018Cancer Biology